2021
DOI: 10.1007/s11011-021-00711-w
|View full text |Cite
|
Sign up to set email alerts
|

Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
10
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
2

Relationship

2
4

Authors

Journals

citations
Cited by 9 publications
(10 citation statements)
references
References 123 publications
0
10
0
Order By: Relevance
“…These associations confirm that increased MS disability may be related to abnormal blood flow to the brain due to cerebral hypoperfusion [2] demonstrating a reduction in cerebral blood flow in pwMS which is associated with hypoxia leading to white matter damage. Oligodendrocytes are extremely vulnerable to a hypoxic environment, resulting in demyelination and an increase in formation of white matter lesions [1,2] .…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…These associations confirm that increased MS disability may be related to abnormal blood flow to the brain due to cerebral hypoperfusion [2] demonstrating a reduction in cerebral blood flow in pwMS which is associated with hypoxia leading to white matter damage. Oligodendrocytes are extremely vulnerable to a hypoxic environment, resulting in demyelination and an increase in formation of white matter lesions [1,2] .…”
Section: Discussionmentioning
confidence: 99%
“…Disability may be transient due to the restoration of the myelin sheaths by stem cells, the oligodendrocyte precursor cells (OPCs) residing in the CNS, emphasizing the importance of understanding what the OPCs require to fulfil this function. Managing MS disability requires more than medicines, as outlined previously by van Rensburg et al [1,3]. People with MS (pwMS) need to be empowered to challenge the present narrative that predicts inevitable progressive disability following an MS diagnosis.…”
Section: Introductionmentioning
confidence: 99%
See 2 more Smart Citations
“…4,5 This has involved pathology-supported genetic testing (PSGT) to search for genetic and environmental risk factors for demyelination. 6,7 Following a study that recruited 118 pwMS to investigate the role of iron in MS, 8 subsequent sub-studies found that MS risk factors fall into two categories: (1) deficiencies : (iron, vitamin D, vitamin B12, antioxidants, unsaturated oils, decreased CNS blood flow) and (2) aggravators : (oxidation/inflammation, smoking, infections, dietary saturated fat, increased cholesterol/homocysteine/obesity; allergies/food sensitivity and psychological stress). The rationale was outlined previously 5,6,7 and in the Discussion below.…”
Section: Introductionmentioning
confidence: 99%